U.S., Nov. 5 -- An application to own the trademark for 'KETOD' has been filed on Aug. 23, 2024.
Owner(s):
Noster Inc.; 35-3, Minamibiraki, Kamiueno-cho,, , JAPAN
Goods and/or Services:
For: Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney ...